Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.

Identifieur interne : 001551 ( Main/Exploration ); précédent : 001550; suivant : 001552

The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.

Auteurs : Ystein Arlov [Norvège] ; Finn L. Aachmann [Norvège] ; Emadoldin Feyzi [Norvège] ; Anders Sundan [Norvège] ; Gudmund Skj K-Br K [Norvège]

Source :

RBID : pubmed:26406104

Descripteurs français

English descriptors

Abstract

Alginate is a promising polysaccharide for use in biomaterials as it is biologically inert. One way to functionalize alginate is by chemical sulfation to emulate sulfated glycosaminoglycans, which interact with a variety of proteins critical for tissue development and homeostasis. In the present work we studied the impact of chain length and flexibility of sulfated alginates for interactions with FGF-2 and HGF. Both growth factors interact with defined sequences of heparan sulfate (HS) at the cell surface or in the extracellular matrix. Whereas FGF-2 interacts with a pentasaccharide sequence containing a critical 2-O-sulfated iduronic acid, HGF has been suggested to require a highly sulfated HS/heparin octasaccharide. Here, oligosaccharides of alternating mannuronic and guluronic acid (MG) were sulfated and assessed by their relative efficacy at releasing growth factor bound to the surface of myeloma cells. 8-mers of sulfated MG (SMG) alginate showed significant HGF release compared to shorter fragments, while the maximum efficacy was achieved at a chain length average of 14 monosaccharides. FGF-2 release required a higher concentration of the SMG fragments, and the 14-mer was less potent compared to an equally sulfated high-molecular weight SMG. Sulfated mannuronan (SM) was subjected to periodate oxidation to increase chain flexibility. To assess the change in flexibility, the persistence length was estimated by SEC-MALLS analysis and the Bohdanecky approach to the worm-like chain model. A high degree of oxidation of SM resulted in approximately twice as potent HGF release compared to the nonoxidized SM alginate. The release of FGF-2 also increased with the degree of oxidation, but to a lower degree compared to that of HGF. It was found that the SM alginates were more efficient at releasing FGF-2 than the SMG alginates, indicating a greater dependence on monosaccharide identity and charge orientation over chain flexibility and charge density.

DOI: 10.1021/acs.biomac.5b01125
PubMed: 26406104


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.</title>
<author>
<name sortKey="Arlov, Ystein" sort="Arlov, Ystein" uniqKey="Arlov " first=" Ystein" last="Arlov"> Ystein Arlov</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aachmann, Finn L" sort="Aachmann, Finn L" uniqKey="Aachmann F" first="Finn L" last="Aachmann">Finn L. Aachmann</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feyzi, Emadoldin" sort="Feyzi, Emadoldin" uniqKey="Feyzi E" first="Emadoldin" last="Feyzi">Emadoldin Feyzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sundan, Anders" sort="Sundan, Anders" uniqKey="Sundan A" first="Anders" last="Sundan">Anders Sundan</name>
<affiliation wicri:level="1">
<nlm:affiliation>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Skj K Br K, Gudmund" sort="Skj K Br K, Gudmund" uniqKey="Skj K Br K G" first="Gudmund" last="Skj K-Br K">Gudmund Skj K-Br K</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26406104</idno>
<idno type="pmid">26406104</idno>
<idno type="doi">10.1021/acs.biomac.5b01125</idno>
<idno type="wicri:Area/PubMed/Corpus">001458</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001458</idno>
<idno type="wicri:Area/PubMed/Curation">001458</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001458</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001321</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001321</idno>
<idno type="wicri:Area/Ncbi/Merge">001279</idno>
<idno type="wicri:Area/Ncbi/Curation">001279</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001279</idno>
<idno type="wicri:Area/Main/Merge">001556</idno>
<idno type="wicri:Area/Main/Curation">001551</idno>
<idno type="wicri:Area/Main/Exploration">001551</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.</title>
<author>
<name sortKey="Arlov, Ystein" sort="Arlov, Ystein" uniqKey="Arlov " first=" Ystein" last="Arlov"> Ystein Arlov</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aachmann, Finn L" sort="Aachmann, Finn L" uniqKey="Aachmann F" first="Finn L" last="Aachmann">Finn L. Aachmann</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feyzi, Emadoldin" sort="Feyzi, Emadoldin" uniqKey="Feyzi E" first="Emadoldin" last="Feyzi">Emadoldin Feyzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sundan, Anders" sort="Sundan, Anders" uniqKey="Sundan A" first="Anders" last="Sundan">Anders Sundan</name>
<affiliation wicri:level="1">
<nlm:affiliation>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K.G. Jebsen Center for Myeloma Research and Centre of Molecular Inflammation Research (CEMIR), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology , Prinsesse Kristinas gate 1, 7030 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Skj K Br K, Gudmund" sort="Skj K Br K, Gudmund" uniqKey="Skj K Br K G" first="Gudmund" last="Skj K-Br K">Gudmund Skj K-Br K</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Biotechnology, Norwegian University of Science and Technology , Sem Sælands vei 6/8, 7034 Trondheim</wicri:regionArea>
<placeName>
<settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biomacromolecules</title>
<idno type="eISSN">1526-4602</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alginates (chemistry)</term>
<term>Cell Line, Tumor</term>
<term>Fibroblast Growth Factor 2 (metabolism)</term>
<term>Glucuronic Acid (chemistry)</term>
<term>Glycosaminoglycans (chemistry)</term>
<term>Heparitin Sulfate (chemistry)</term>
<term>Hepatocyte Growth Factor (metabolism)</term>
<term>Hexuronic Acids (chemistry)</term>
<term>Hexuronic Acids (pharmacology)</term>
<term>Humans</term>
<term>Multiple Myeloma (drug therapy)</term>
<term>Oligosaccharides (chemistry)</term>
<term>Oligosaccharides (pharmacology)</term>
<term>Sulfates (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide glucuronique ()</term>
<term>Acides hexuroniques ()</term>
<term>Acides hexuroniques (pharmacologie)</term>
<term>Alginates ()</term>
<term>Facteur de croissance des hépatocytes (métabolisme)</term>
<term>Facteur de croissance fibroblastique de type 2 (métabolisme)</term>
<term>Glycosaminoglycanes ()</term>
<term>Humains</term>
<term>Héparitine sulfate ()</term>
<term>Lignée cellulaire tumorale</term>
<term>Myélome multiple (traitement médicamenteux)</term>
<term>Oligosaccharides ()</term>
<term>Oligosaccharides (pharmacologie)</term>
<term>Sulfates ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Alginates</term>
<term>Glucuronic Acid</term>
<term>Glycosaminoglycans</term>
<term>Heparitin Sulfate</term>
<term>Hexuronic Acids</term>
<term>Oligosaccharides</term>
<term>Sulfates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Fibroblast Growth Factor 2</term>
<term>Hepatocyte Growth Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Hexuronic Acids</term>
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Multiple Myeloma</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Facteur de croissance des hépatocytes</term>
<term>Facteur de croissance fibroblastique de type 2</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acides hexuroniques</term>
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Myélome multiple</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line, Tumor</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Acide glucuronique</term>
<term>Acides hexuroniques</term>
<term>Alginates</term>
<term>Glycosaminoglycanes</term>
<term>Humains</term>
<term>Héparitine sulfate</term>
<term>Lignée cellulaire tumorale</term>
<term>Oligosaccharides</term>
<term>Sulfates</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Alginate is a promising polysaccharide for use in biomaterials as it is biologically inert. One way to functionalize alginate is by chemical sulfation to emulate sulfated glycosaminoglycans, which interact with a variety of proteins critical for tissue development and homeostasis. In the present work we studied the impact of chain length and flexibility of sulfated alginates for interactions with FGF-2 and HGF. Both growth factors interact with defined sequences of heparan sulfate (HS) at the cell surface or in the extracellular matrix. Whereas FGF-2 interacts with a pentasaccharide sequence containing a critical 2-O-sulfated iduronic acid, HGF has been suggested to require a highly sulfated HS/heparin octasaccharide. Here, oligosaccharides of alternating mannuronic and guluronic acid (MG) were sulfated and assessed by their relative efficacy at releasing growth factor bound to the surface of myeloma cells. 8-mers of sulfated MG (SMG) alginate showed significant HGF release compared to shorter fragments, while the maximum efficacy was achieved at a chain length average of 14 monosaccharides. FGF-2 release required a higher concentration of the SMG fragments, and the 14-mer was less potent compared to an equally sulfated high-molecular weight SMG. Sulfated mannuronan (SM) was subjected to periodate oxidation to increase chain flexibility. To assess the change in flexibility, the persistence length was estimated by SEC-MALLS analysis and the Bohdanecky approach to the worm-like chain model. A high degree of oxidation of SM resulted in approximately twice as potent HGF release compared to the nonoxidized SM alginate. The release of FGF-2 also increased with the degree of oxidation, but to a lower degree compared to that of HGF. It was found that the SM alginates were more efficient at releasing FGF-2 than the SMG alginates, indicating a greater dependence on monosaccharide identity and charge orientation over chain flexibility and charge density. </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Norvège</li>
</country>
<region>
<li>Trøndelag</li>
</region>
<settlement>
<li>Trondheim</li>
</settlement>
</list>
<tree>
<country name="Norvège">
<region name="Trøndelag">
<name sortKey="Arlov, Ystein" sort="Arlov, Ystein" uniqKey="Arlov " first=" Ystein" last="Arlov"> Ystein Arlov</name>
</region>
<name sortKey="Aachmann, Finn L" sort="Aachmann, Finn L" uniqKey="Aachmann F" first="Finn L" last="Aachmann">Finn L. Aachmann</name>
<name sortKey="Feyzi, Emadoldin" sort="Feyzi, Emadoldin" uniqKey="Feyzi E" first="Emadoldin" last="Feyzi">Emadoldin Feyzi</name>
<name sortKey="Skj K Br K, Gudmund" sort="Skj K Br K, Gudmund" uniqKey="Skj K Br K G" first="Gudmund" last="Skj K-Br K">Gudmund Skj K-Br K</name>
<name sortKey="Sundan, Anders" sort="Sundan, Anders" uniqKey="Sundan A" first="Anders" last="Sundan">Anders Sundan</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001551 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001551 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26406104
   |texte=   The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26406104" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021